Rhubarb and Angiotensin Converting Enzyme Inhibitor (RACE II)
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
Terminated
unable to meet recruitment goal
Other terminated trials from National Center for Complementary and Integrative Health (NCCIH)
- Pain · Phase NA · Oct 2023
- Generalized Anxiety Disorder · Phase NA · May 2023
- Cognitive Impairment · Phase EARLY_PHASE1 · Dec 2020
- Chronic, Non-neuropathic Back Pain · Phase NA · Jun 2019
- Rheumatoid Arthritis · Phase PHASE1 · Sep 2017
See all terminations from National Center for Complementary and Integrative Health (NCCIH)
Other Diabetic Kidney Disease trials with similar outcome
A PHASE2 clinical study on Diabetic Kidney Disease, this trial is terminated or withdrawn. The trial is conducted by National Center for Complementary and Integrative Health (NCCIH) and has accumulated 11 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jan 2019 — Jan 2021 [monthly]
Terminated PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Terminated PHASE2
Phase: NA → PHASE2
-
Jun 2018 — Dec 2018 [monthly]
Terminated NA
-
Dec 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Dec 2017 [monthly]
Terminated NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Center for Complementary and Integrative Health (NCCIH)
- Wake Forest University
For direct contact, visit the study record on ClinicalTrials.gov .